POLARx Post Approval Study (POLARx PAS)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT06170606
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT06170606
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT06170606. Allocation not applicable; no masking; primary purpose treatment. Start 2024-06-28 (actual); primary completion 2026-05-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- POLARx Post Approval Study (POLARx PAS)
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- Boston Scientific Cardiac Cryoablation System
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct06170606- Content hash
4aa03bfdf7c347c4c316e14759cd14514609c7137b519abe372f2209f69a1b6c